Reducing Environmental Impact: Carbon Pricing and VAT Reform
A new Nature Food study by Plinke, Sureth and Kalkuhl shows that applying carbon pricing or reforming value‑added tax (VAT) on food could markedly lower Europe’s food‑related greenhouse‑gas emissions. Quantitative analysis predicts higher prices on carbon‑intensive items will curb demand for meat and dairy while shifting consumers toward plant‑based alternatives. The authors argue a progressive VAT can make sustainable choices affordable for lower‑income households, preserving equity. They stress that policy design must reflect regional dietary habits and socio‑economic conditions across Europe.
Congress Advances PRV Reauthorization, NIH Funding, Multi-Cancer Detection Coverage
Congress is moving a bipartisan spending package that would reauthorize pediatric priority review vouchers, safeguard NIH funding, and extend Medicare coverage to multi‑cancer early‑detection tests. The House Appropriations Committee released a bill to fund the government through September and avoid...
Bipartisan Deal Paves Medicare Path for Grail's Cancer Test
In case you missed it, one apparent winner in today's bipartisan healthcare deal is the diagnostics firm Grail. $GRAL The company’s "multi-cancer early detection" test is already available, but in order to succeed it must leap multiple hurdles, including receiving...
Datwyler Collabs with Stevanato and LTS to Advance Home-Based Biologics
Datwyler, LTS Device Technologies, and Stevanato Group announced a strategic partnership to create an integrated platform for self‑administered large‑volume subcutaneous biologics. The solution combines Stevanato’s EZ‑fill® 10‑20 mL cartridges, Datwyler’s NeoFlex™ spray‑coated plungers, and LTS’s Sorrel wearable injector, targeting doses up...
Nasal Passage Cell Response to Common Cold Virus Determines Sickness Severity
Yale researchers used an air‑liquid interface organoid of human nasal epithelium to show that a rapid interferon (IFN) response limits rhinovirus infection to less than 2% of cells, while blocking IFN triggers widespread viral replication. The study also identified a...
Detecting Drought Stress in Trees From the Air
Researchers at Switzerland’s WSL used drone‑borne multispectral cameras to map drought stress across seven native tree species during the hot summer of 2023. By measuring photoprotective pigment signals and canopy greenness, they identified species‑specific responses, such as rapid oak recovery...
Tracer Reveals How Environmental DNA Moves Through Lakes and Rivers
A Cornell‑Granada team created a synthetic DNA tracer to map environmental DNA (eDNA) transport in freshwater. They released 1 µg of the tracer in Cayuga Lake, tracked its dispersion for 33 hours, and built a hydrodynamic model that predicts eDNA source locations....
Proteasomes: A Novel Approach to Target the Immune System
Proteolysis‑targeting chimeras (PROTACs) are leveraging the ubiquitin‑proteasome system to degrade disease‑causing proteins, opening treatment avenues for previously undruggable targets such as aggressive childhood cancers and resistant triple‑negative breast cancer. Major pharmaceutical companies—including Amgen, BMS, J&J, AbbVie, AstraZeneca and Novartis—have advanced...
Government Funding Bill Features PBM Reforms, Voucher Reauthorization
The U.S. House will vote on a bipartisan continuing resolution to keep the federal government operating beyond Jan. 30, bundling sweeping pharmacy‑benefit‑manager (PBM) reforms and a reauthorization of the children's health voucher program. The PBM provisions aim to increase pricing transparency,...
PDI Overexpression Improves Vascular Contractility in Aged Blood Vessels
Researchers discovered that overexpressing protein disulfide isomerase (PDI) restores contractile function in aged vascular smooth muscle. The study links age‑related loss of sulfenylation‑dependent actin remodeling to reduced arterial stiffness. In murine models, PDI overexpression re‑established F‑actin assembly and rescued vessel...
EU Parliament Adopts Stricter Drug Stockpiling Rules Under Critical Medicines Act
The European Parliament approved amendments to the Critical Medicines Act, introducing stricter drug‑stockpiling requirements and new financial incentives for manufacturers. The legislation mandates a minimum safety‑stock level—roughly 5 % of a product’s annual EU consumption—and tighter reporting on supply‑chain data. Companies...
Valneva Withdraws Chikungunya Vaccine From US
Valneva announced the withdrawal of its chikungunya vaccine from the United States, removing the product from the market and suspending a post‑marketing study. The decision follows internal safety assessments and regulatory feedback. The company has not provided detailed efficacy data,...
A Trade-Off Coming Back to Haunt Bispecific Antibody Development
Bispecific antibody programs are increasingly confronting early platform decisions that were once deemed interchangeable. Choices made to simplify development or streamline regulatory pathways have embedded mechanistic assumptions that now limit efficacy ceilings and differentiation. As multiple immuno‑oncology bispecifics converge on...
Virtual Staining Advances: AI Uses Cell Context to Improve Imaging Accuracy
Researchers at Ben‑Gurion University have introduced a contextual AI system that translates label‑free microscope images into virtual fluorescent stains, dramatically improving accuracy. By feeding the model metadata such as cell shape, neighborhood, and colony position, the AI can correctly label...
PH‐Responsive Psoralen Delivery System for Infected Bone Defects: Spatiotemporal Photothermal Disinfection Coupled with Osteogenesis and Osteoclast Regulation
Researchers introduced a pH‑responsive nanoplatform—PSO/ZIF‑8@PDA (PZP) nanoparticles—that couples photothermal activity with controlled psoralen release. The system degrades rapidly in acidic, infection‑laden bone tissue, delivering antibacterial action first, then promoting osteogenesis as the environment normalizes. In vitro studies identified an optimal...
West Launches New Prefillable Syringe System that Streamlines Biologic Delivery
West Pharmaceutical Services introduced the Synchrony S1 prefillable syringe system at Pharmapack 2026, targeting biologics and combination products. The platform offers 1 ml and 2.25 ml staked‑needle options as well as Luer‑lock configurations, paired with NovaPure and FluroTec barrier‑film plungers. By delivering a single‑source,...
Aspect Biosystems and Novo Nordisk – Enter New Phase of Partnership to Develop Curative Medicines for Diabetes
Novo Nordisk and Aspect Biosystems have entered a new partnership phase to develop curative cellular medicines for diabetes. Aspect will acquire Novo Nordisk's stem‑cell‑derived islet and hypoimmune technologies and lead development, manufacturing, and commercialization, while Novo Nordisk retains rights to...
Clinician Groups Ask Court to Overturn CDC's Childhood Vaccine Overhaul
Leading physician organizations have filed a federal lawsuit seeking to overturn the CDC’s recent overhaul of the U.S. childhood vaccine schedule. The groups contend the new recommendations are reckless and lack adequate safety evidence. The legal challenge targets the addition...
Longevity Biotech Shifts Focus to Root Causes
Longevity biotech now targets root causes rather than single diseases. This is a paradigm shift in medicine
Inovalon Launches Clinical Trial Eligibility Screener to Accelerate Trial Recruitment
Inovalon introduced a Clinical Trial Eligibility Screener, an API that evaluates patient eligibility in real time using longitudinal primary source data. The service applies natural language processing to parse free‑text inclusion and exclusion criteria, delivering pass, fail or inconclusive results...
Exploring Postoperative Feeding Challenges in Neonatal Surgery
The provided input contains only a list of article titles, dates, and thumbnail descriptions without any substantive article text, author information, or detailed content.
J&J Bets on Isomorphic for AI-Powered Drug Hunt
Johnson & Johnson’s Janssen Biotech unit has entered a cross‑modality, multi‑target research collaboration with Isomorphic Labs, the Alphabet‑backed AI drug‑discovery start‑up. The partnership combines Isomorphic’s planet‑scale computing and AI‑driven design engine with J&J’s experimental and development capabilities, covering both small‑molecule...
The Shift From Containment to Protection: Packaging Trends Impacting Pharma
In 2025 pharmaceutical packaging moved from simple containment to active protection, with functional materials that mitigate moisture, oxygen and impurity risks. Companies are embedding safety features such as child resistance directly into paperboard, while sustainability mandates drive mono‑material, recyclable designs....
Key Mitochondrial Genes Linked to Necrotizing Enterocolitis
A multi‑center genomic study has pinpointed five mitochondrial genes that significantly increase the risk of necrotizing enterocolitis (NEC) in preterm infants. Researchers analyzed DNA from over 1,200 neonates and correlated gene expression patterns with clinical outcomes, revealing a clear mitochondrial...
Hepatitis B: Are We Edging Closer to a Cure?
Hepatitis B infects about 254 million people and caused 1.1 million deaths in 2022, with chronic infection leading to cirrhosis and liver cancer. Researchers are pursuing a “functional cure”—sustained undetectable HBV DNA and loss of HBsAg—through novel antivirals, antisense oligonucleotides, and therapeutic...
Aficamten (CK-3773274)
Cytokinetics’ aficamten (Myqorzo®) received FDA approval as an oral cardiac myosin inhibitor for obstructive hypertrophic cardiomyopathy (oHCM). The drug is a next‑generation, reversible, allosteric inhibitor designed to simplify dose‑titration compared with the existing agent mavacamten. In a Phase 3 trial, aficamten...
CRVS Shows Promising AD Efficacy, Needs Tissue Validation
$CRVS +57% premarket on AD Cohort-4: randomized PBO-controlled signal (EASI-75 75%, mean EASI −72% vs −40% PBO; p=0.035) with clean safety, real but fragile (n=12 vs 12; 10 PBO-evaluable). 📝No skin-biopsy disclosed. While exiting progress serum PD != tissue reversal....
Pfizer Makes $530M Vaccine Play With Novavax Deal After Rumors of BioNTech Pullback
Pfizer has committed $30 million upfront and up to $500 million in milestone payments to partner with Novavax, gaining a non‑exclusive license to the Matrix‑M adjuvant technology. The agreement allows Pfizer to apply the adjuvant to up to two disease areas, though...
ViiV Ownership Shifts as Pfizer Sells Its Stake
Pfizer is selling its ViiV Healthcare stake for $1.875 billion, reducing its involvement in the HIV joint venture. Shionogi’s ownership more than doubles to 21.7% while GSK retains a 78.3% majority and aims to push ViiV sales beyond £7 billion this year....
New AI-Powered Wearable Helps Stroke Patients Communicate by Mouthing Words
Researchers at the University of Cambridge and Beihang University unveiled Revoice, an AI‑powered wearable choker that translates silently mouthed words into speech for stroke survivors with dysarthria. The non‑invasive device senses throat vibrations and carotid pulse, then uses two AI...
Revolutionary NIR-II Imaging Spotlights Liver Tumors
A new near‑infrared II (NIR‑II) imaging platform has demonstrated unprecedented clarity in visualizing liver tumors, achieving sub‑millimeter resolution at depths up to five centimeters. In early‑phase clinical trials, the technology identified lesions 30% earlier than conventional ultrasound and MRI, enabling...
Revolutionizing C‒N Bond Formation From Water-Based Nitrogen
A research team announced a novel catalytic method that forms carbon‑nitrogen (C‑N) bonds directly from water‑based nitrogen sources, eliminating the need for hazardous ammonia gas. The process operates under ambient temperature and pressure, achieving yields above 85% for a broad...
Bovine Colostrum Boosts Nutrition in Preterm Infants
Researchers have demonstrated that supplementing preterm infant diets with bovine colostrum significantly enhances protein and immunoglobulin intake. Clinical trials showed a 15% reduction in feeding intolerance and a modest improvement in weight gain during the first month of life. The...
Teladoc’s Mental Health Arm BetterHelp Has Quietly Expanded the Use of AI
BetterHelp, Teladoc's flagship mental‑health platform, has quietly broadened its use of artificial intelligence across multiple service layers. The AI tools now support client intake, symptom triage, and therapist recommendation workflows, aiming to streamline care delivery. BetterHelp claims the expansion will...
Rigid‐Flexible Layered Immobilization Enables Precise Confinement and Dynamic Activation of Small Enzymes
A novel rigid‑flexible layered immobilization combines metal‑organic framework (MOF) micropores with hydrogel macropores to stabilize small enzymes (10–50 kDa) while preserving activity. The dual‑pore architecture reduces substrate‑enzyme distance by 34.2% and prevents leakage, enabling 40 consecutive cycles of high conversion for...
Triboelectric Wearable Devices for Wound Healing: Materials, Mechanisms, and Innovative Designs
A new review outlines triboelectric wearable devices—primarily triboelectric nanogenerators—as self‑powered platforms for wound healing. It details core design elements, including triboelectric and electrode materials, and structural strategies that enable electrical stimulation without external power. The paper explains multi‑scale mechanisms such...
CRVS Shows Promise Yet Remains Early, Uncertain
Lots of haters on $CRVS and yes the way they’ve disclosed data over time is a little iffy but 🤷🏻♂️. Active drug. New data looks solid. They ought to be able to fund the P2. They’ve got...
Out‑of‑the‑Money ABVX Calls Hint at Genuine Deal
I know (and understand why) there’s a lot of speculation around the credibility of the La Lettre articles on $ABVX M&A. I have no idea whether the reporting is legit. Could it be made up BS as part of some...
Corvus' New Phase 1 Atopic Dermatitis Data Meet High Expectations
Corvus Pharmaceuticals announced that its Phase 1 trial for a novel severe atopic dermatitis therapy met predefined safety and efficacy benchmarks. The data demonstrated favorable tolerability and early signs of clinical improvement, prompting the company to advance the program into...
CDC Deputy Downplays Losing US Measles Elimination Status
Would the #CDC's principal deputy director view it as a public health loss for the US if the country loses its #measles elimination status? "Not really," Dr. Ralph Abraham said at a press conference today. https://t.co/JXb3tlOrsu
RFK Jr. Seeks Overhaul of Vaccine Compensation Panel
RFK Jr. is moving to remake a panel involved in that compensating people who are injured by vaccines. It could have big consequences. By @ChelseaCirruzzo. https://t.co/S98hMN6Vd0
J&J, Isomorphic Sign Research Deal for AI-Made Molecules
Isomorphic Labs, a Google DeepMind spin‑out specializing in AI‑driven drug design, announced its third pharmaceutical collaboration, signing a multi‑target research agreement with Johnson & Johnson. The partnership will leverage Isomorphic’s generative‑AI platform to design novel molecules across several therapeutic areas....
Mapping Tumor‑Immune Spatial Interactions in Solid Cancers
Decoding the spatial dynamics of tumor and immune cell interactions in solid cancers https://t.co/AHgt77Ee2t https://t.co/1Xxkt45JlD
Use Repetition to Slash Bioinformatics Analysis Time
Are you ready to level up your bioinformatics skills? Let’s talk about repetition—a key concept that can save you hours in real-world data analysis. https://t.co/2Dtc9hz46e
Freenome Expands AI and Deep Learning Initiatives Accelerated by NVIDIA
Freenome announced a partnership with NVIDIA to boost its blood‑based early cancer screening using accelerated deep‑learning infrastructure. The collaboration will scale training of Freenome’s proprietary fragment‑level deep learning (FLDL) models and create an open‑source cfDNA methylation foundation model. NVIDIA’s BioNeMo...
Shared Decision Making Misused to Question Vaccine Science
Shared clinical decision making was devised to help patients & their doctors make choices when the answer isn't clear cut. People who devised the approach fear it's being hijacked to undermine decades of study supporting #vaccines, @EricBoodman writes. https://t.co/JMmaHTI7eg
Kennedy's Push Could Drive Vaccine Makers Out
Vaccine proponents worry that Kennedy will drive manufacturers from the US market by adding autism to the vaccine injury compensation program & unleashing a flood of litigation. The path to that change is through a committee he's currently "acip-ing." (clearing...
A Discovery Platform for Transcription Factors Capable of Tissue Rejuvenation
Researchers introduced a high‑throughput discovery platform that screens individual transcription factors for their ability to reverse cellular aging. Using aged human fibroblasts, the system highlighted more than a dozen candidates and rigorously validated four—E2F3 and EZH2 (activation) and STAT3 and...
Intronic Reads in 10x 3′ UMI Data Explained
You’re analyzing 10x Genomics single-cell RNA-seq and notice lots of intronic reads. Wait—wasn’t this a 3′ UMI-based assay for mature mRNA? Let’s unpack why introns show up—and why they matter. 🧵 https://t.co/cDeb8dfLAS
Corvus Pill Yields 75% EASI‑75 Response in Eczema Trial
$CRVS Corvus pill shows promise in early-stage eczema trial 75% of participants treated with soquelitinib achieved EASI 75 after 8 weeks compared to 20% of placebo participants offered a placebo. https://t.co/XlOmX0GUZf